No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Needham Maintains Hologic(HOLX.US) With Buy Rating, Maintains Target Price $90
Positive Outlook for Hologic Amidst Revenue and EPS Adjustments: Analyst Recommends Buy
Here's Why Hologic (HOLX) Fell More Than Broader Market
Needham Reiterates Buy on Hologic, Maintains $90 Price Target
Hologic Agrees With CDC to Develop Reagents for H5N1 Bird Flu Testing
Peering Into Hologic's Recent Short Interest